193 related articles for article (PubMed ID: 33033841)
1. Lung injury induced by pyrrolizidine alkaloids depends on metabolism by hepatic cytochrome P450s and blood transport of reactive metabolites.
He Y; Lian W; Ding L; Fan X; Ma J; Zhang QY; Ding X; Lin G
Arch Toxicol; 2021 Jan; 95(1):103-116. PubMed ID: 33033841
[TBL] [Abstract][Full Text] [Related]
2. Hepatic cytochrome P450s play a major role in monocrotaline-induced renal toxicity in mice.
Yao J; Li CG; Gong LK; Feng CC; Li CZ; Gao M; Luan Y; Qi XM; Ren J
Acta Pharmacol Sin; 2014 Feb; 35(2):292-300. PubMed ID: 24362331
[TBL] [Abstract][Full Text] [Related]
3. Prenatal exposure to pyrrolizidine alkaloids induced hepatotoxicity and pulmonary injury in fetal rats.
Guo Y; Xiao D; Yang X; Zheng J; Hu S; Wu P; Li X; Kou H; Wang H
Reprod Toxicol; 2019 Apr; 85():34-41. PubMed ID: 30771476
[TBL] [Abstract][Full Text] [Related]
4. Impact of hepatic P450-mediated biotransformation on the disposition and respiratory tract toxicity of inhaled naphthalene.
Kovalchuk N; Kelty J; Li L; Hartog M; Zhang QY; Edwards P; Van Winkle L; Ding X
Toxicol Appl Pharmacol; 2017 Aug; 329():1-8. PubMed ID: 28527914
[TBL] [Abstract][Full Text] [Related]
5. The toxicokinetic and metabolism of structurally diverse pyrrolizidine alkaloids in rats.
To YC; Pan Y; Yan X; He Y; Lin G
J Ethnopharmacol; 2024 Mar; 321():117390. PubMed ID: 37956911
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary toxicity is a common phenomenon of toxic pyrrolizidine alkaloids.
Song Z; He Y; Ma J; Fu PP; Lin G
J Environ Sci Health C Toxicol Carcinog; 2020; 38(2):124-140. PubMed ID: 32500835
[TBL] [Abstract][Full Text] [Related]
7. Sex difference in monocrotaline-induced developmental toxicity and fetal hepatotoxicity in rats.
Luo J; Yang X; Qiu S; Li X; Xiang E; Fang Y; Wang Y; Zhang L; Wang H; Zheng J; Guo Y
Toxicology; 2019 Apr; 418():32-40. PubMed ID: 30825512
[TBL] [Abstract][Full Text] [Related]
8. A mouse model with liver-specific deletion and global suppression of the NADPH-cytochrome P450 reductase gene: characterization and utility for in vivo studies of cyclophosphamide disposition.
Gu J; Chen CS; Wei Y; Fang C; Xie F; Kannan K; Yang W; Waxman DJ; Ding X
J Pharmacol Exp Ther; 2007 Apr; 321(1):9-17. PubMed ID: 17218484
[TBL] [Abstract][Full Text] [Related]
9. Application of hepatic cytochrome b
Reed L; Indra R; Mrizova I; Moserova M; Schmeiser HH; Wolf CR; Henderson CJ; Stiborova M; Phillips DH; Arlt VM
Toxicol Appl Pharmacol; 2019 Mar; 366():64-74. PubMed ID: 30685480
[TBL] [Abstract][Full Text] [Related]
10. Determination of the role of target tissue metabolism in lung carcinogenesis using conditional cytochrome P450 reductase-null mice.
Weng Y; Fang C; Turesky RJ; Behr M; Kaminsky LS; Ding X
Cancer Res; 2007 Aug; 67(16):7825-32. PubMed ID: 17699788
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of mouse hepatic CYP3A protein by 3-methylcholanthrene does not require cytochrome P450-dependent metabolism.
Lee C; Ding X; Riddick DS
Drug Metab Dispos; 2013 Oct; 41(10):1782-6. PubMed ID: 23846873
[TBL] [Abstract][Full Text] [Related]
12. Toxicokinetic Interaction between Hepatic Disposition and Pulmonary Bioactivation of Inhaled Naphthalene Studied Using
Kovalchuk N; Zhang QY; Kelty J; Van Winkle L; Ding X
Drug Metab Dispos; 2019 Dec; 47(12):1469-1478. PubMed ID: 31594800
[TBL] [Abstract][Full Text] [Related]
13. Comparative Study of Hepatotoxicity of Pyrrolizidine Alkaloids Retrorsine and Monocrotaline.
Yang X; Li W; Sun Y; Guo X; Huang W; Peng Y; Zheng J
Chem Res Toxicol; 2017 Feb; 30(2):532-539. PubMed ID: 28095673
[TBL] [Abstract][Full Text] [Related]
14. The role of renal proximal tubule P450 enzymes in chloroform-induced nephrotoxicity: utility of renal specific P450 reductase knockout mouse models.
Liu S; Yao Y; Lu S; Aldous K; Ding X; Mei C; Gu J
Toxicol Appl Pharmacol; 2013 Oct; 272(1):230-7. PubMed ID: 23732084
[TBL] [Abstract][Full Text] [Related]
15. Female-specific activation of pregnane X receptor mediates sex difference in fetal hepatotoxicity by prenatal monocrotaline exposure.
Xiang E; Guo Q; Dai YG; Sun XX; Liu J; Fan CP; Wang YQ; Qiu SK; Wang H; Guo Y
Toxicol Appl Pharmacol; 2020 Nov; 406():115137. PubMed ID: 32682830
[TBL] [Abstract][Full Text] [Related]
16. Effect of Cytochrome P450 Reductase Deficiency on 2-Amino-9H-pyrido[2,3-b]indole Metabolism and DNA Adduct Formation in Liver and Extrahepatic Tissues of Mice.
Turesky RJ; Konorev D; Fan X; Tang Y; Yao L; Ding X; Xie F; Zhu Y; Zhang QY
Chem Res Toxicol; 2015 Dec; 28(12):2400-10. PubMed ID: 26583703
[TBL] [Abstract][Full Text] [Related]
17. Exposure to benzo[a]pyrene of Hepatic Cytochrome P450 Reductase Null (HRN) and P450 Reductase Conditional Null (RCN) mice: Detection of benzo[a]pyrene diol epoxide-DNA adducts by immunohistochemistry and 32P-postlabelling.
Arlt VM; Poirier MC; Sykes SE; John K; Moserova M; Stiborova M; Wolf CR; Henderson CJ; Phillips DH
Toxicol Lett; 2012 Sep; 213(2):160-6. PubMed ID: 22759596
[TBL] [Abstract][Full Text] [Related]
18. Role of small intestinal cytochromes p450 in the bioavailability of oral nifedipine.
Zhang QY; Kaminsky LS; Dunbar D; Zhang J; Ding X
Drug Metab Dispos; 2007 Sep; 35(9):1617-23. PubMed ID: 17567730
[TBL] [Abstract][Full Text] [Related]
19. In vivo mechanisms of tissue-selective drug toxicity: effects of liver-specific knockout of the NADPH-cytochrome P450 reductase gene on acetaminophen toxicity in kidney, lung, and nasal mucosa.
Gu J; Cui H; Behr M; Zhang L; Zhang QY; Yang W; Hinson JA; Ding X
Mol Pharmacol; 2005 Mar; 67(3):623-30. PubMed ID: 15550675
[TBL] [Abstract][Full Text] [Related]
20. Intestinal and hepatic biotransformation of pyrrolizidine alkaloid N-oxides to toxic pyrrolizidine alkaloids.
Yang M; Ma J; Ruan J; Ye Y; Fu PP; Lin G
Arch Toxicol; 2019 Aug; 93(8):2197-2209. PubMed ID: 31222523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
